Skip to content

Symptomatic Treatment of Acute Uncomplicated Diverticulitis

Symptomatic Treatment of Acute Uncomplicated Diverticulitis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02219698
Enrollment
158
Registered
2014-08-19
Start date
2014-07-31
Completion date
Unknown
Last updated
2015-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diverticulitis

Brief summary

The purpose of this study is to determine the safety and efficacy of symptomatic treatment (i.e. without antimicrobial drugs) of acute uncomplicated diverticulitis.

Interventions

DRUGIbuprofen
DRUGParacetamol

Sponsors

Vatsatautien tutkimussäätiö - foundation
CollaboratorUNKNOWN
Mary and Georg Ehrnroot's foundation
CollaboratorUNKNOWN
Finnish Surgical society
CollaboratorUNKNOWN
Martti I. Turunen Foundation
CollaboratorUNKNOWN
Governmental competitive funds (EVO)
CollaboratorUNKNOWN
Helsinki University Central Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Computed tomography-diagnosed acute uncomplicated\* diverticulitis * No abscess, fistula, obstruction and distant intra- or retroperitoneal air. Pericolic air allowed.

Exclusion criteria

* Already commenced antimicrobial medication * Immunosuppression (e.g. diabetes, corticosteroid medication, immunosuppressive medication, chemotherapy, chronic liver disease) * Suspicion of generalized peritonitis * Organ dysfunction * Another infection requiring antimicrobial medication * Pregnancy * Age \< 18 years or \> 90 years * Missing written consent

Design outcomes

Primary

MeasureTime frameDescription
Complications of diverticulitis30 days from allocationIncidence of complications of diverticulitis (abscess, free perforation, need for surgery)

Secondary

MeasureTime frameDescription
Rate of re-admissions30 days from dischargeNumber patients re-admitted to hospital
Recurrence of diverticulitis10 yearsNumber of recurrent diverticulitis within follow-up
Mortality30 days from allocationNumber of patients deceased
Need for elective sigmoid resection10 yearsNumber of patients that have undergone elective sigmoid resection
Length of hospital stay (days)At the end of the hospital stay, an expected average of 2 days
Commencement of antimicrobial drugFor the duration of hospital stay, an expected average of 2 daysNumber of patients that have received antimicrobial drugs
Late complication of diverticulitis10 yearsNumber of patients who develop late complications of diverticulitis e.g. fistula, stricture
Stoma rate10 yearsNumber of patients who receive a stoma
Need for emergency surgery for diverticulitis on another admission10 yearsNumber of patients requiring emergency surgery for diverticulitis on another admission

Countries

Finland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 13, 2026